Discontinuation of Medications With Limited Benefit at End of Life in Community‐Dwelling Older Veterans
Journal of the American Geriatrics Society · 2026-05 · 74 (5) · 1326-1338
DOI: 10.1111/jgs.70381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 02.04.2026. Verfasst von Joshua M Thorpe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthcare Evaluation Research and Promotion; Veterans Affairs (VA). Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Deprescriptions, Terminal Care, Veterans. Die Arbeit nennt 49 Literaturangaben. Gefördert von: U.S. Department of Veterans Affairs.
Themen: Palliativpflege
Abstract (Originalsprache)
Background
Discontinuation of medications with limited benefits (LBM) in patients nearing the end of life can reduce burden, adverse events, and costs, and enhance quality of life. However, most research on end‐of‐life prescribing has focused on nursing homes or hospice settings.
Aims
To describe the prevalence of LBM use and discontinuation or deintensification over the last year of life in community‐dwelling older veterans with advanced life‐limiting conditions.
Design
Retrospective, national cohort study of U.S. veteran decedents (≥ 65 years) with advanced life‐limiting conditions who died between October 2016 and September 2017.
Setting
Community‐residing, non‐hospice older veterans. LBM users were identified using consensus‐based criteria and assessed for discontinuation over the last year of life. We estimated LBM discontinuation rate ratios using multivariable robust Poisson regression.
Results
Among 37,193 decedents (mean age 78 years), 73% were on at least one LBM (e.g., statins, oral antidiabetics, antihypertensives, antithrombotics, anti‐ulcer, or antidementia drugs) entering the last year (baseline). Of these baseline LBM users, 22.0% experienced at least one LBM discontinuation over their final year. Veterans residing in more rural counties had lower LBM discontinuation rates than those in large metropolitan counties. Discontinuation rates were also higher in the Midwest or South compared to the Northeast or West. Veterans with documented clinical indicators of limited life expectancy (e.g., pressure ulcers, malnutrition) or those receiving specialty palliative care, were more likely to have LBMs discontinued.
Conclusion
Among community‐dwelling older veterans in their final year of life, 73% were receiving at least one LBM at the start of that year, and 78% of these individuals continued LBM use until death. These rates parallel those reported in long‐term care populations and underscore the need for community‐based healthcare providers to routinely screen for LBMs and support appropriate medication discontinuation in older patients with advanced illnesses and limited life expectancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Healthcare Evaluation Research and Promotion; Veterans Affairs (VA). Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
- U.N.C. Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
- Center for Medication Safety, Veterans Affairs, Hines, Illinois, USA.
- Yale University School of Nursing, Orange, Connecticut, USA.
- Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham VA Medical Center, Durham, North Carolina, USA.
- Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
ORCID-Profile: Joshua M Thorpe, Kelvin A Tran, Shelli L Feder, Carolyn T Thorpe
Förderung
- U.S. Department of Veterans Affairs
Zitieren
APA
Thorpe, J. M., Tran, K. A., Aspinall, S. L., Feder, S. L., Kaufman, B. G., Kutney-Lee, A., Mor, M. K., Schleiden, L. J., Sileanu, F. E., Thorpe, C. T., & Van Houtven, C. H. (2026). Discontinuation of Medications With Limited Benefit at End of Life in Community‐Dwelling Older Veterans. Journal of the American Geriatrics Society, 74(5), 1326-1338. https://doi.org/10.1111/jgs.70381
Vancouver
Thorpe JM, Tran KA, Aspinall SL, Feder SL, Kaufman BG, Kutney-Lee A, et al. Discontinuation of Medications With Limited Benefit at End of Life in Community‐Dwelling Older Veterans. Journal of the American Geriatrics Society. 2026;74(5):1326-1338. doi:10.1111/jgs.70381
BibTeX
@article{Thorpe2026,
author = {Thorpe, Joshua M and Tran, Kelvin A and Aspinall, Sherrie L and Feder, Shelli L and Kaufman, Brystana G and Kutney-Lee, Ann and Mor, Maria K and Schleiden, Loren J and Sileanu, Florentina E and Thorpe, Carolyn T and Van Houtven, Courtney H},
title = {Discontinuation of Medications With Limited Benefit at End of Life in Community‐Dwelling Older Veterans},
journal = {Journal of the American Geriatrics Society},
year = {2026},
volume = {74},
number = {5},
pages = {1326--1338},
doi = {10.1111/jgs.70381}
}
EUVIMED